BioData World Congress EU 2018
28th – 29th November 2018
Congress Centre Basel
BioData World Congress transpiring on the 28-29th November in Basel is the worlds-leading event for individuals working within Big Data and AI in life sciences and healthcare research. to drive forwards big data use in Pharmaceuticals.
The event was originally created with the support of leading institutes such as EMBL-EBI, Genomics England, Sanger Institute and the NHS and has since been commissioned by Roche and Merck along with others. Biodata brings together global heads of IT, data, analytics, digital, CDOs, CIOs, bioinformatics, genetics, oncology, rare disease, computational biology, translational medicine etc from leading pharmaceutical companies. BioData takes place over 12 tracks this year, including: Storage, IT and Management, Bioinformatics, AI and Machine Learning, Big Data in Cancer, Data Integration & Infrastructure, Big Data in Rare Diseases, Analytics Platforms and Data Sets, Next Gen Sequencing, Data Management, Genomics in Clinical Trials, Real World Evidence and Precision Medicine along with a Hackathon and two Start up Streams.
We have moved the 2018 edition to Basel as the Canton of Basel-Stadt are investing in the event long term. This will put us on the doorstep of a number of leading industry individuals such as Novartis and Roche.
There will be 200 speakers and 700+ attendees. In terms of speakers 70% will be pharma, 20% research institutes, 10% Academia. 70% of the attendees will be European based, 20% US and 10% rest of world.
The Biodata World Congress presents a lucrative opportunity for you to meet new customers and to grow your client base as you benefit from being able to sell to both our buy-side and sell-side audience.
Bertrand Bodson, Chief Digital Officer, Novartis
Sue Hill, Chief Scientific Officer, NHS England
Philippe Marc, Global Head of Integrated Data Sciences, Novartis Institutes for BioMedical Research (NIBR)
Diego Ardigo, Global Head of Rare Diseases, Chiesi
Vikram Bajaj, Managing Director, Forsite Capital Management, Former CSO Grail, Co-Founder, Verily (Google Life Sciences)
Ian Pepper, CTO/Head of Strategy and Integration Architecture, Novartis
Peter Speyer, Global Head of Real World Evidence Solutions, Novartis
Dirk Voelkel, Chief Technology Officer, GE Healthcare
Slavé Petrovski, VP and Head of Genome Analytics, AstraZeneca
Govinda Rao Bhisetti, Principal Investigator and Head of Computational Chemistry, Biogen
If you are interested in attending, make sure to register today and benefit from the 10% partner discount. Simply use the voucher code LRYB when you register online https://bit.ly/2BzlOyI
Rare Revolution Editor